Posaconazole for paediatric patients: status of development and future perspectives

Mycoses
Andreas H Groll, Thomas Lehrnbecher

Abstract

Posaconazole is a novel oral antifungal triazole with potent and broad-spectrum antifungal activity, favourable pharmacokinetic properties and a limited spectrum of adverse events. The compound has documented clinical efficacy in the settings of oropharyngeal candidiasis, refractory aspergillosis, fusariosis, zygomycosis, and as antifungal prophylaxis in high-risk patients with acute myeloblastic leukaemia or graft-vs.-host disease. Whereas, posaconazole is approved for use in adults, however, the appropriate dosage and the safety of the compound have not been systematically investigated in paediatric age groups. This paper reviews the relevant pharmacological characteristics of posaconazole, the published data on its use in paediatric patients without therapeutic alternative and perspectives for the clinical development in paediatric patients at risk for invasive fungal infections.

References

Mar 15, 2001·Lancet·A H Groll
May 20, 2003·Infectious Disease Clinics of North America·Andreas H GrollThomas J Walsh
Apr 7, 2004·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·D WexlerM Laughlin
Aug 26, 2004·Antimicrobial Agents and Chemotherapy·Philip KrieterRachel Courtney
Dec 4, 2004·The Journal of Allergy and Clinical Immunology·Sarah M WynneSteven M Holland
May 13, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Brahm H SegalSteven M Holland
Aug 19, 2005·Expert Review of Anti-infective Therapy·Andreas H Groll, Thomas J Walsh
Mar 3, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jo-Anne H van BurikDimitrios P Kontoyiannis
Apr 1, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jose A VazquezRandi Isaacs
May 18, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Issam I RaadAndrew J Ullmann
Aug 1, 2006·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Koen De DeckerPhilippe G Jorens
Sep 12, 2006·Mycoses·G NotheisUwe Wintergerst
Nov 15, 2006·Antimicrobial Agents and Chemotherapy·Angela Sansone-ParsonsRandall Stoltz
Dec 5, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas J WalshJohn R Perfect
Jan 11, 2007·Antimicrobial Agents and Chemotherapy·Gopal KrishnaLisa Pedicone
Jan 24, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Daniel J SkiestRandi Isaacs
Jan 26, 2007·The New England Journal of Medicine·Andrew J UllmannSimon Durrant
Jan 26, 2007·The New England Journal of Medicine·Oliver A CornelyDavid Angulo-Gonzalez
Jun 15, 2007·Archives of Ophthalmology·Christopher D GelstonEric A F Simoes

❮ Previous
Next ❯

Citations

May 9, 2009·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·W Behrens-Baumann
May 19, 2011·The Pediatric Infectious Disease Journal·Christopher C Blyth
Feb 24, 2011·Antimicrobial Agents and Chemotherapy·Athanasios ChatzimoschouEmmanuel Roilides
May 1, 2013·Expert Review of Anti-infective Therapy·Nevin Hatipoglu, Husem Hatipoglu
Apr 30, 2009·Expert Review of Anti-infective Therapy·Lyn ThomasMike Sharland
Nov 7, 2012·British Journal of Clinical Pharmacology·Jodi M LestnerWilliam W Hope
Jul 19, 2011·Mycoses·Aspasia KatragkouTheoklis E Zaoutis
Jul 26, 2012·The Journal of Infectious Diseases·Stefanie S V HenrietAdilia Warris

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.